Adenoviral capsid modulates secretory compartment organization and function in acinar epithelial cells from rabbit lacrimal gland

Gene Therapy

Volumn 11, Issue 12, 2004, Pages 970-981

  Wang, Y ^a   Xie, J ^a   Yarber, F A ^a   Mazurek, C ^a   Trousdale, M D ^b   Kauwe Medina, L K ^c   Kasahara, N ^d   Hamm Alvarez, S F ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; Adenovirus capsid; Exocytosis; Lacrimal gland; Rab3D

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CARBACHOL; RAB PROTEIN; TEAR PROTEIN;

ACINAR CELL; ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; EPITHELIUM CELL; EXOCYTOSIS; FEMALE; GENETIC TRANSDUCTION; IMMUNOFLUORESCENCE; LACRIMAL GLAND; NONHUMAN; PRIORITY JOURNAL; RABBIT; SECRETORY VESICLE; ULTRAVIOLET RADIATION; VIRUS CAPSID; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; BIOLOGICAL MARKERS; CAPSID; CELLS, CULTURED; EPITHELIAL CELLS; EXOCYTOSIS; FEMALE; FLOW CYTOMETRY; GENE THERAPY; LACRIMAL APPARATUS; MICROSCOPY, CONFOCAL; RAB3 GTP-BINDING PROTEINS; RABBITS; SECRETORY VESICLES; TRANSDUCTION, GENETIC; ULTRAVIOLET RAYS; VIRUS INACTIVATION;

ADENOVIRIDAE; ORYCTOLAGUS CUNICULUS;

EID: 3142757278     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302247     Document Type: Article

References (55)

1. Cordeiro MF et al. Molecular therapy in ocular wound healing. Br J Ophthalmol 1998; 83: 1219-1224.
2. Borras T. Recent developments in ocular gene therapy. Exp Eye Res 2003; 76: 643-652.
3. Zhu Z et al. TNF-inhibitor gene expression suppresses lacrimal gland immunopathology and ocular surface disease in a rabbit model of autoimmune dacryoadenitis. Cornea 2003; 22: 25-31.
4. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
5. Greber UF, Willetts M, Webster P, Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993; 75: 477-486.
6. Mathias P, Wickham T, Moore M, Nemerow G. Multiple adenovirus serotypes use αv integrins for infection. J Virol 1994; 68: 6811-6814.
7. Kass-Eisler A et al. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1994; 1: 395-402.
8. Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
9. Barr D et al. Strain-related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient strains. Gene Therapy 1995; 2: 151-155.
10. Yang Y, Xiang Z, Ertl HCJ, Wilson JM. Upregulation of class 1 MHC antigens by interferon-γ is necessary for the T cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc Natl Acad Sci USA 1995; 92: 7257-7261.
11. Yang Y, Haecker SE, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 1996; 5: 1713-1726.
12. Reichel MB et al. Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Therapy 1998; 5: 1038-1046.
13. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Therapy 2003; 10: 977-982.
14. Medina-Kauwe LK. Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Deliv Rev 2003; 55: 1485-1496.
15. Dartt DA. Signal transduction and activation of the lacrimal gland. In: Albert DM, Jacobiec FA (eds) Principles and Practice of Ophthalmology, 2nd edn. Saunders: Philadelphia, 1994, pp 458-465.
16. Fullard R. Tear proteins arising from lacrimal tissue. In: Albert DM and Jacobiec FA (eds) Principles and Practice of Ophthalmology, 2nd edn. Saunders: Philadelphia, 1994, pp 473-479.
17. Mircheff AK. Water and electrolyte secretion and fluid modification. In: Albert DM and Jacobiec FA (eds) Principles and Practice of Ophthalmology, 2nd edn. Saunders: Philadelphia, 1994, pp 466-472.
18. Fox RI, Stern M, Michelson P. Update in Sjögren's syndrome. Curr Opin Rheumatol 2000; 12: 391-398.
19. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea 2000; 19: 644-649.
20. Ang RT, Dartt DA, Tsubota, K. Dry eye after refractive surgery. Curr Opin Ophthalmol 2001; 12: 318-322.
21. Gierow JP, Lambert RW, Mircheff AK. Fluid phase endocytosis by isolated rabbit lacrimal gland acinar cells. Exp Eye Res 1995; 60: 511-525.
22. Hamm-Alvarez SF et al. Cholinergic stimulation of lacrimal acinar cells promotes redistribution of membrane-associated kinesin and the secretory protein, β-hexosaminidase, and increases kinesin motor activity. Exp Eye Res 1997; 64: 141-156.
23. da Costa SR et al. Microtubules facilitate the stimulated secretion of β-hexosaminidase in lacrimal acinar cells. J Cell Sci 1998; 111: 1267-1276.
24. Robinson MS. Coats and vesicle budding. Trends Cell Biol 1997; 7: 99-102.
25. Ohnishi H et al. Rab3D localizes to zymogen granules in rat pancreatic acini and other exocrine glands. Am J Physiol 1996; 271: G531-G538.
26. Valentijn JA et al. Rab3D localizes to secretory granules in rat pancreatic acinar cells. Eur J Cell Biol 1996; 70: 33-41.
27. Wang Y et al. Cytoplasmic dynein participates in apically-targeted stimulated secretory traffic in primary rabbit lacrimal acinar epithelial cells. J Cell Sci 2003; 116: 2051-2065.
28. Fujita-Yoshigaka J et al. Vesicle-associated membrane protein 2 is essential for cAMP-regulated exocytosis in rat parotid acinar cells. J Biol Chem 1996; 271: 13130-13134.
29. Cotton M et al. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci USA 1992; 89: 6094-6098.
30. Yang Y, Greenough K, Wilson JM. Transient immune blockage prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse. Gene Therapy 1996; 3: 412-420.
31. Larkin DF et al. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 1996; 61: 363-370.
32. Hoffman LM, Maguire AM, Bennett J. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci 1997; 38: 2224-2233.
33. Kamata Y et al. Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. Mol Ther 2001; 4: 307-312.
34. Pfeffer SR. Rab GTPases: specifying and deciphering organelle identity and function. Trends Cell Biol 2001; 11: 487-491.
35. Bergelson JM et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
36. Chiu CY, Mathias P, Nemerow, GR, Stewart PL. Structure of adenovirus complexed with its internalization receptor, αvβ5 integrin. J Virol 1999; 73: 6759-6768.
37. Li E, Stupack D, Bokoch GM, Nemerow GR. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J Virol 1998; 72: 8806-8812.
38. Li E et al. Adenovirus endocytosis via αv integrins requires phophoinositide-3-OH Kinase. J Virol 1998; 72: 2055-2061.
39. Li E et al. Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 2000; 275: 14729-14735.
40. Suomalainen M et al. Microtubule-dependent plus- and minus-end directed motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol 1999; 144: 657-672.
41. Leopold PL et al. Dynein and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Human Gene Ther 2000; 11: 151-165.
42. Heilker R, Spiess M, Crottet P. Recognition of sorting signals by clathrin adaptors. BioEssays 1999; 21: 558-567.
43. Kirchhausen T. Adaptors for clathrin-mediated traffic. Annu Rev Cell Dev Biol 1999; 15: 705-732.
44. Tooze SA, Martens GJM, Hutter WB. Secretory granule biogenesis: rafting to the SNARE. Trends Cell Biol 2001; 11: 116-122.
45. Greenberg ME et al. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J 1997; 16: 6964-6976.
46. Craig HM, Pandori MW, Guatelli JC. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci USA 1998; 95: 11229-11234.
47. Fender P et al Adenovirus dodecahedron, a new vector for human gene transfer. Nat Biotechnol 1997; 15: 52-56.
48. Medina-Kauwe LK, Kasahara N, Kedes LH. 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins. Gene Therapy 2001; 8: 797-803.
49. Lai CM, Lai YKY, Rakoczy PB. Adenovirus and adeno-associated virus vectors. DNA Cell Biol 2002; 21: 895-913.
50. Gordon JS, Aoki K, Kinchington PR. Adenovirus keratoconjunctivitis. In: Pepose JS, Holland GN, Wilhelmus KR (eds). Ocular Infection and Immunity. Mosby: St Louis, 1996, pp 877-894.
51. Ford E, Nelson KE, Warren D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev 1987; 9: 244-261.
52. Trousdale MD et al. Studies of adenovirus-induced eye disease in the rabbit model. Invest Ophthamol Vis Sci 1995; 36: 2740-2748.
53. Zhang L et al. Protein phosphatase inhibitors alter cellular microtubules and reduce carbachol-dependent protein secretion in lacrimal acini. Curr Eye Res 2000; 20: 373-383.
54. da Costa SR et al. Impairing actin filament or syndapin functions promotes accumulation of clathrin-coated vesicles at the apical plasma membrane of polarired cells. Mol Cell Biol 2003; 14: 4397-4413.
55. Laskey RA, Mills AD. Quantitative film detection of 3 H and 14C in polyacrylamide gels by fluorography. Eur J Biochem 1975; 56: 335-341.